Cerebrospinal Fluid Flow Extends to Peripheral Nerves
There has been a very recent cutting-edge neuroscience study that has turned our traditional understanding of the nervous system on its head. The study revealed through a series of ingenious experiments that cerebrospinal fluid (CSF) is not only confined to the central nervous system (CNS), but can also propagate through the peripheral nervous system (PNS) to support the functioning of the entire nervous system. This discovery has led to a breakthrough in the field of neuroscience.
Creative Biolabs summarizes and shares this finding in hopes of helping researchers better understand the mechanisms of some neurodegenerative diseases. The table below shows the related services we provide.
Our Services | Descriptions |
In Vitro Services | We offer customized cell culture model development services, cell viability assays, neuronal plasticity assays, neuroinflammation assays, and neurochemistry assays. Our commitment to excellence has driven us to develop high-end in vitro services. |
In Vivo Services | Creative Biolabs has extensive experience in conducting safety and efficacy in vivo assessments to evaluate the pharmacological effects of drug candidates on a range of neurological disorders. We are committed to providing a variety of animal models such as Alzheimer's disease (AD) animal models, Parkinson's disease (PD) animal models, and Huntington's disease (HD) mouse models for scientific research needs. |
What is CSF? What are Its Functions?
CSF is the fluid in the central nervous system. It is produced by the choroid plexus in the brain, about 0.5 liters per day, and its main function is to provide a physical cushion for the brain and spinal cord, preventing damage to nerve tissue from external shocks. It is also responsible for providing nutrients and helping to remove metabolic waste. CSF flows through the brain's ventricular system and then enters the subarachnoid space that surrounds the brain and spinal cord, where it flows in slow pulses at low pressure.
For a long time, scientists thought that the role of CSF was confined to the central nervous system, which we know as the “brain and spinal cord”. The peripheral nervous system - responsible for transmitting instructions from the brain to the limbs and organs - was thought to have nothing to do with CSF. The conventional wisdom is that CSF flows only within the protective layers of the brain and spinal cord, and that the peripheral nerves have their own separate nutrient supply system. But this new study revolutionizes that perception.
For CSF related research, we also offer a range of research tools, including but not limited to the following:
Cat. No | Product Name | Product Category |
NRZP-0822-ZP495 | NeuroBiologics™ Monkey Cerebrospinal Fluid | Biospecimens |
NRZP-0822-ZP496 | NeuroBiologics™ Rat Cerebrospinal Fluid | Biospecimens |
NRZP-0822-ZP497 | NeuroBiologics™ Mouse Cerebrospinal Fluid | Biospecimens |
NRZP-0822-ZP498 | NeuroBiologics™ Pig Cerebrospinal Fluid | Biospecimens |
NRZP-0822-ZP491 | NeuroBiologics™ Human Cerebrospinal Fluid | Biospecimens |
NRZP-0822-ZP493 | NeuroBiologics™ Synthetic Cerebrospinal Fluid | Biospecimens |
NRZP-0822-ZP494 | NeuroBiologics™ Dog Cerebrospinal Fluid | Biospecimens |
NRZP-0822-ZP499 | NeuroBiologics™ Minipig Cerebrospinal Fluid | Biospecimens |
NRZP-0822-ZP500 | NeuroBiologics™ Bovine Cerebrospinal Fluid | Biospecimens |
NRZP-0822-ZP501 | NeuroBiologics™ Custom Disease Related Human Cerebrospinal Fluid | Biospecimens |
Experimental Findings: CSF Surprisingly Extends to Peripheral Nerves!
Using nanotechnology, the research team injected extremely tiny gold particles, which are similar in size to proteins and nutrient molecules in CSF, into the brains of mice. The researchers then tracked the flow of these particles through the nervous system using advanced imaging techniques.
It turned out that these 1.9-nanometer gold particles were able to flow from the brain's lateral ventricles, the main production area for CSF, through the central nervous system and further to peripheral nerves, such as the sciatic nerve, which is responsible for leg movement. This is the first clear demonstration that the flow of CSF is not confined to the brain and spinal cord, but can cross the attachment points of nerve roots, enter the fiber layer of peripheral nerves, and ultimately reach within the axons of distal nerves.
In living mice, gold nanoparticles were injected as probes into the CSF in the lateral ventricles to track the flow pattern of CSF and to determine whether the CSF is able to flow into peripheral nerves under physiological conditions.
Why were gold nanoparticles chosen as a tracking tool for CSF flow?
- The availability of nanoparticles in multiple sizes
- The low permeability of nanogold enhances the flow
- The enhanced gold staining method allows for greater detection sensitivity in light and electron microscopy
The Flow of CSF Has a “Screening Mechanism”
In addition to the 1.9-nanometer gold particles, the researchers used larger 15-nanometer particles for comparison. The results showed that the 15-nanometer particles were unable to travel from the central nervous system to the peripheral nerves, but instead remained in the subarachnoid space of the central nerves. This demonstrates that there is a “size filtration mechanism” for the flow of CSF - only molecules smaller than a certain size are able to pass through the blood-brain barrier (BBB) and the blood-neurological barrier (BNB) and enter the peripheral nerves.
- CSF solutes enter peripheral nerves from the nerve root attachment zone (RAZ).
- Electron microscopy identifies the flow of CSF in the connective tissue envelope of a peripheral nerve.
- CSF penetrates Schwann cells up to the axonal level.
This discovery is highly significant because it tells us that CSF does not only act in the CNS, but that it carries important nutrients and metabolic wastes throughout the nervous system through a set of filtering mechanisms. This flow across the central-peripheral nervous system may play an important role in the maintenance of healthy peripheral nerves.
Research Highlights
- Advanced technology - Using gold nanoparticle tracking technology and high-resolution electron microscopy, the team successfully tracked the flow path of CSF from the brain to the peripheral nerves, clearly demonstrating how the particles exhibit different flow patterns at different sizes.
- Rigorous controlled experiments - By comparing different sizes of gold particles, the study verifies the existence of a “size limitation” in the flow of CSF, which provides valuable reference data for future drug design.
- Breakthrough discovery - This is the first experimental evidence that CSF can cross the CNS and enter the PNS, which overturns traditional knowledge.
Why is This Discovery So Important?
- Breaking down the barriers between central and peripheral to unify nervous system functions
- New avenues for treating peripheral nerve disorders
- New strategies for drug delivery
This discovery undoubtedly opens a new chapter in basic research on the nervous system. In the future, we may be able to utilize this new CSF flow mechanism to design more precise therapeutic strategies for neurological diseases. For example, through the CSF delivery system, specific drugs can be directly applied to the diseased peripheral nerves, avoiding the complex blood-brain barrier obstruction in the traditional drug delivery method.
If you have further thoughts on this research, please contact us to explore the possibilities of neuroscience!
- NeuroMab™ Anti-TREM2 Antibody(NRP-0422-P792) (Cat#: NRP-0422-P792)
- NeuroMab™ Mouse Anti-LRP1 Monoclonal Antibody (CBP3363) (Cat#: NAB-0720-Z6479)
- NeuroMab™ Anti-Tau Antibody(NRP-0422-P2275) (Cat#: NRP-0422-P2275)
- NeuroMab™ Anti-TNFα BBB Shuttle Antibody(NRZP-1022-ZP4105) (Cat#: NRZP-1022-ZP4105)
- NeuroMab™ Rabbit Anti-Alpha-synuclein (CBP1631) (Cat#: NAB-08-PZ079)
- Mouse Anti-Human α-Synuclein Phospho (Tyr39) (CBP3706) (Cat#: NAB201250LS)
- NeuroMab™ Anti-EPHB2 Antibody(NRP-0422-P1220) (Cat#: NRP-0422-P1220)
- NeuroMab™ Anti-CD32b Antibody(NRP-0422-P1803) (Cat#: NRP-0422-P1803)
- NeuroMab™ Anti-Alpha Synuclein BBB Shuttle Antibody(NRZP-1022-ZP4050) (Cat#: NRZP-1022-ZP4050)
- NeuroMab™ Mouse Anti-SHANK3 Monoclonal Antibody (CBP929) (Cat#: NAB-0720-Z3477)
- Rat Retinal Muller Cell Line, Immortalized (Cat#: NCL-21P6-192)
- Immortalized Human Cerebral Microvascular Endothelial Cells (Cat#: NCL-2108-P020)
- Human Glial (Oligodendrocytic) Hybrid Cell Line (MO3.13) (Cat#: NCL-2108P34)
- iNeu™ Human Motor Neurons (Cat#: NCL-2103-P71)
- Rat Glioma Cell Line C6 (Cat#: NCL2110P346)
- iNeu™ Human Sensory Neurons (Cat#: NCL-2103-P62)
- Human Retinal Epithelial Cell ARPE-19 (Cat#: NCL2110P069)
- Mouse Glioma Cell Line GL-261-Luc (Cat#: NCL-2108P06)
- Human Brain Vascular Adventitial Fibroblasts (Cat#: NCL-21P6-014)
- iNeu™ Human Oligodendrocyte Progenitor Cells (OPCs) (Cat#: NCL-2103-P49)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- pAAV-syn-FLEX-jGCaMP8f-WPRE (Cat#: NTA-2106-P064)
- pAAV-syn-jGCaMP8f-WPRE (Cat#: NTA-2106-P061)
- rAAV-E-SARE-Cre-ERT2-PEST-WPRE-hGH polyA (Cat#: NTA-2010-TT342)
- Dextran, Cy5 Labeled, 2000 kDa (Cat#: NRZP-0722-ZP22)
- pAAV-syn-FLEX-jGCaMP8s-WPRE (Cat#: NTA-2106-P066)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- Dextran, NHS Activated, 40 kDa (Cat#: NRZP-0722-ZP124)
- pAAV-syn-FLEX-jGCaMP8m-WPRE (Cat#: NTA-2106-P065)
- Dextran-FITC (Cat#: NTA-2011-ZP110)
- AAV-mDLX-CRE-tdTomato (Cat#: NRZP-0622-ZP721)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)